Johnson & Johnson at TD Cowen Healthcare Conference Transcript
Good morning. I'm Joshua Jennings from the TD Cowen Medical Devices Research Team, and we are thrilled to have, Executive Vice President and CFO Johnson & Johnson, Joe Wolk joining us.
Joe, it's, great to see you in person. Thank you for participating this year, and, it's been a long little while since I've seen you in person. So great to see you.
It's nice to see you, Josh, and thank you for your interest in Johnson and Johnson. Certainly, do appreciate it.
Questions & Answers
Absolutely, we're -- going to focus a little bit on the high level, strategy and the MedTech franchise. That's our wheelhouse. I know you guys have a much bigger wheelhouse with the pharma unit. It's been an incredible stock performance year in 2025 for Johnson & Johnson, and a lot of that was driven by both MedTech and Innovative
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
